alpha7nAChR agonist (180 Life Sciences)

N/A

Report date: 2025/01/26 18:34:43
NME

Base Information

Drug Namealpha7nAChR agonist (180 Life Sciences)
Drug Alias Namealpha-7 nicotinic acetylcholine receptor agonists (180 Life Sciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit agonists
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies180 Life Sciences Corp
China Registration ClassN/A

Develop Information

Active Companies180 Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A